OABI
Price
$2.23
Change
-$0.08 (-3.46%)
Updated
Apr 3, 02:52 PM (EDT)
Capitalization
281.52M
VIGL
Price
$1.71
Change
-$0.06 (-3.39%)
Updated
Apr 3, 04:18 PM (EDT)
Capitalization
82.61M
34 days until earnings call
Ad is loading...

OABI vs VIGL

Header iconOABI vs VIGL Comparison
Open Charts OABI vs VIGLBanner chart's image
OmniAb
Price$2.23
Change-$0.08 (-3.46%)
Volume$200
Capitalization281.52M
Vigil Neuroscience
Price$1.71
Change-$0.06 (-3.39%)
Volume$100
Capitalization82.61M
OABI vs VIGL Comparison Chart
Loading...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OABI vs. VIGL commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OABI is a Hold and VIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (OABI: $2.31 vs. VIGL: $1.77)
Brand notoriety: OABI and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OABI: 76% vs. VIGL: 43%
Market capitalization -- OABI: $281.52M vs. VIGL: $82.61M
OABI [@Biotechnology] is valued at $281.52M. VIGL’s [@Biotechnology] market capitalization is $82.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OABI’s FA Score shows that 1 FA rating(s) are green whileVIGL’s FA Score has 1 green FA rating(s).

  • OABI’s FA Score: 1 green, 4 red.
  • VIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, both OABI and VIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OABI’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 4 bullish TA indicator(s).

  • OABI’s TA Score: 4 bullish, 6 bearish.
  • VIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than OABI.

Price Growth

OABI (@Biotechnology) experienced а -5.14% price change this week, while VIGL (@Biotechnology) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.30%. For the same industry, the average monthly price growth was -10.41%, and the average quarterly price growth was -14.40%.

Reported Earning Dates

OABI is expected to report earnings on May 11, 2023.

VIGL is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OABI($282M) has a higher market cap than VIGL($82.6M). VIGL YTD gains are higher at: 4.118 vs. OABI (-34.887). OABI has higher annual earnings (EBITDA): -58.92M vs. VIGL (-89.23M). VIGL has more cash in the bank: 97.8M vs. OABI (59.4M). VIGL has less debt than OABI: VIGL (12.9M) vs OABI (23.8M). OABI has higher revenues than VIGL: OABI (20.4M) vs VIGL (0).
OABIVIGLOABI / VIGL
Capitalization282M82.6M341%
EBITDA-58.92M-89.23M66%
Gain YTD-34.8874.118-847%
P/E RatioN/AN/A-
Revenue20.4M0-
Total Cash59.4M97.8M61%
Total Debt23.8M12.9M184%
TECHNICAL ANALYSIS
Technical Analysis
OABIVIGL
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 7 days ago
64%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
55%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
66%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISOPX16.23N/A
N/A
Voya SmallCap Opportunities Port A
AFPAX4.13N/A
N/A
DSS AmericaFirst Income A
MNBRX19.36N/A
N/A
Manning & Napier Pro-Blend Extnd Term R
HFQIX6.45N/A
N/A
Janus Henderson Global Equity Income I
SLYCX14.00N/A
N/A
SEI Large Cap Y (SIMT)

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with TECH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+1.10%
TECH - OABI
40%
Loosely correlated
+1.80%
ALEC - OABI
39%
Loosely correlated
+1.72%
AVIR - OABI
38%
Loosely correlated
+1.05%
NTLA - OABI
37%
Loosely correlated
+9.69%
VCYT - OABI
37%
Loosely correlated
+1.93%
More